DEFINITION of encephalitis

Encephalitis is inflammation of the brain parenchyma (the functional neural tissue itself, as distinguished from the meninges) resulting in neurological signs and symptoms including altered mental status, seizures, focal deficits, and in severe cases coma; it is distinguished from meningitis, which involves only the meningeal coverings, though the two frequently coexist as meningoencephalitis (G04.90 unspecified). The pathophysiological mechanism varies by etiology: in infectious encephalitis, direct viral invasion of neurons and glial cells triggers cellular necrosis and inflammatory infiltration (most classically seen in herpes simplex virus type 1 encephalitis with temporal lobe predilection); in autoimmune encephalitis, antibody-mediated or T-cell-mediated attack on neuronal surface antigens — such as NMDA receptors in anti-NMDA receptor encephalitis (G04.81) — disrupts synaptic function without necessarily causing structural destruction. Encephalitis may be physiologically classified as primary (direct CNS invasion by the pathogen) or secondary/parainfectious (immune-mediated demyelination following a systemic infection, as in acute disseminated encephalomyelitis, G04.01); the distinction is critical for treatment, as secondary forms respond to immunotherapy while primary infectious forms require antimicrobial agents. The most clinically critical subtypes encountered in inpatient coding include viral encephalitis (A86, B00.4, A83.0-A83.9), autoimmune encephalitis (G04.81), bacterial/other infectious encephalitis (code to the underlying organism with G05.3 as manifestation), post-infectious/ADEM (G04.01), and toxic encephalitis (G92.9). Encephalitis is distinguished from encephalopathy — a broader term for brain dysfunction that is metabolic, toxic, or structural in origin without necessarily implying inflammation; encephalopathy codes (e.g., G92.9 toxic, G93.40 unspecified) are not interchangeable with encephalitis codes and the distinction must be supported by clinical and CSF documentation.


ETYMOLOGY of encephalitis

greek

ComponentOriginMeaning
encephal-Greek enkephalos (en-KEF-ah-los), from en- (“in”) + kephalē (“head”)brain,” literally “that which is in the head” — combining form denoting the brain or brain parenchyma
-itisGreek -itis (-EYE-tis), feminine form of -itēs (adjective suffix)Noun-forming suffix — “inflammation of”; originally used in Greek as an adjective agreeing with nosos (“disease”), then frozen as an independent suffix in medical Latin and English

The word entered English in the 1840s as encephalitis (noun), formed in modern medical Latin from Greek enkephalos — literally “that which is within the head.” The component en- (“in”) + kephalē (“head”) reflects the ancient Greek anatomical conception of the brain as the organ housed within the skull. The root enkephalos connects encephalitis to a large encephal- family: encephalopathy (enkephalos + pathos → “disease/disorder of the brain”), encephalomyelitis (enkephalos + myelos + -itis → “inflammation of brain and spinal cord”), encephalocele (enkephalos + kele → “herniation of brain tissue through skull”), and electroencephalography (elektron + enkephalos + graphein → “electrical recording of brain activity”). The suffix -itis is the single most productive suffix in clinical medicine, appearing in meningitis, myelitis, neuritis, vasculitis, and hundreds of other terms. The root kephalē (“head”) independently generates cephalalgia, hydrocephalus, microcephaly, and brachycephaly.


🔀 ALIASES / ALTERNATE TERMS

  • Encephalitic (adjective form — clinical collocations include “encephalitic syndrome,” “encephalitic presentation,” and “encephalitic phase” of rabies or flavivirus infection)
  • Meningoencephalitis (simultaneous inflammation of brain parenchyma and meninges; coded to G04.90 unspecified or to specific etiology code; very common combined presentation in bacterial and viral CNS infections)
  • Encephalomyelitis (inflammation of both brain and spinal cord; includes acute disseminated encephalomyelitis G04.01 and myalgic encephalomyelitis G93.32; distinguish carefully in coding)
  • Cerebritis (clinical term for early diffuse bacterial brain parenchymal infection prior to frank abscess formation; typically coded to bacterial encephalitis or cerebral abscess category G06.0 depending on documentation)
  • Acute disseminated encephalomyelitis (ADEM) (post-infectious or post-vaccination immune-mediated demyelinating encephalitis; G04.01; important to distinguish from primary viral encephalitis in children)
  • Anti-NMDA receptor encephalitis (autoimmune encephalitis caused by antibodies against GluN1 subunit of NMDA receptors; G04.81; classic presentation in young women, often paraneoplastic with ovarian teratoma)
  • Limbic encephalitis (autoimmune or paraneoplastic encephalitis targeting limbic structures; presents with memory loss, psychiatric symptoms, seizures; coded to G04.81 or paraneoplastic code depending on documentation)
  • Viral encephalitis, unspecified (coded to A86 when specific viral etiology is not identified; commonly used in community-acquired cases without confirmed pathogen)
  • Herpes simplex encephalitis (most common sporadic fatal encephalitis in adults; caused by HSV-1 with temporal lobe tropism; B00.4; IV acyclovir is standard treatment)
  • Japanese encephalitis (mosquito-borne flavivirus encephalitis; A83.0; reportable disease; vaccine-preventable)
  • West Nile encephalitis (arboviral neuroinvasive disease; A92.31; coded specifically — do not use A86 when West Nile is confirmed)
  • Toxic encephalitis / Encephalopathy (brain dysfunction due to exogenous toxins, medications, or metabolic derangements; G92.9 unspecified toxic encephalopathy; not true encephalitis — distinguish carefully in documentation and coding)

🔗 RELATED TERMS

  • encephalopathy — the most critical distinction in inpatient coding: encephalopathy is diffuse brain dysfunction due to metabolic, toxic, hypoxic, or structural causes WITHOUT necessarily implying inflammation; coded separately (G92.9 toxic, G93.40 unspecified, G93.41 metabolic); physicians frequently document “encephalopathy” when clinical findings may support “encephalitis” — query when CSF pleocytosis or neuroimaging supports inflammation
  • Meningitis — inflammation limited to the meningeal coverings without parenchymal involvement; coded to G00.x-G03.x range; distinguished from encephalitis by CSF pattern, imaging, and clinical presentation; coexistence → meningoencephalitis
  • Cerebral abscess — focal, pus-filled collection within brain parenchyma (late evolution of cerebritis); G06.0; distinguished from encephalitis by its discrete, walled-off structure on imaging and surgical amenability
  • myelitis — inflammation of the spinal cord; G04.91 unspecified; shares inflammatory mechanism with encephalitis; combined form is encephalomyelitis G04.90
  • Ventriculitis — inflammation of the ventricular ependymal lining, often complicating bacterial meningitis or CNS device infection; G04.90 or coded to underlying organism; important inpatient complication to capture
  • Demyelination — loss of myelin sheath from axons; the primary pathological mechanism in post-infectious (ADEM) and autoimmune forms of encephalitis; distinguishes secondary from primary infectious encephalitis on MRI
  • Cytokine storm — dysregulated, excessive systemic inflammatory response that can drive and complicate severe viral encephalitis (e.g., in influenza-associated encephalitis); coded as additional diagnosis when documented
  • Herpes simplex virus (HSV) — the most common cause of sporadic viral encephalitis in immunocompetent adults; HSV-1 has temporal lobe tropism; CSF PCR is the gold standard for diagnosis; treatment is IV acyclovir
  • Arbovirus — arthropod-borne virus; category includes agents of Japanese encephalitis (A83.0), West Nile virus (A92.31), Eastern equine encephalitis (A83.2), and La Crosse encephalitis (A83.5); epidemiologically seasonal and geographically clustered
  • Autoimmune encephalitis — a broad category of antibody- or T-cell-mediated encephalitis not caused by infection; the most common antibody-mediated form is anti-NMDA receptor encephalitis (G04.81); treatment is immunotherapy (steroids, IVIG, plasmapheresis), not antivirals
  • Paraneoplastic encephalitis — encephalitis triggered by immune response to a distant neoplasm (most commonly ovarian teratoma, small cell lung cancer, thymoma); code to G13.1 or G04.81 per documentation, plus the underlying neoplasm
  • Lumbar puncture / Cerebrospinal fluid analysis — essential diagnostic procedure for encephalitis workup; CSF PCR, cell count, glucose, protein, and cytology drive etiologic coding; CPT 62270 for diagnostic LP

CODING CORNER


🏥 ICD-10-CM CODES

Viral Encephalitis — Mosquito-Borne (A83.x)

CodeDescription
A83.0Japanese encephalitis
A83.1Western equine encephalitis
A83.2Eastern equine encephalitis
A83.3St. Louis encephalitis
A83.4Australian encephalitis
A83.5California encephalitis (La Crosse encephalitis)
A83.6Rocio virus disease
A83.8Other mosquito-borne viral encephalitis
A83.9Mosquito-borne viral encephalitis, unspecified

Viral Encephalitis — Tick-Borne (A84.x)

CodeDescription
A84.0Far Eastern tick-borne encephalitis (Russian spring-summer encephalitis)
A84.1Central European tick-borne encephalitis
A84.81Powassan virus disease
A84.89Other tick-borne viral encephalitis
A84.9Tick-borne viral encephalitis, unspecified

Other Viral Encephalitis (A85.x / A86 / A92.3x)

CodeDescription
A85.0Enteroviral encephalitis (enteroviral encephalomyelitis)
A85.1Adenoviral encephalitis
A85.2Arthropod-borne viral encephalitis, unspecified
A85.8Other specified viral encephalitis (includes von Economo-Cruchet disease)
A86Unspecified viral encephalitis
A92.31West Nile virus infection with encephalitis

Herpesviral CNS Infections (B00.x / B01.x / B02.x / B10.x)

CodeDescription
B00.4Herpesviral encephalitis (HSV encephalitis — excludes HHV-6, coded to B10.01)
B01.11Varicella encephalitis and encephalomyelitis
B02.0Zoster encephalitis (VZV encephalitis)
B10.01Other human herpesvirus 6 encephalitis
B10.09Other human herpesvirus infection of CNS, other

Other Infectious Encephalitis (B94.x / A39.x / A17.x)

CodeDescription
A17.82Tuberculous meningoencephalitis
A39.81Meningococcal encephalitis
A85.8Other specified viral encephalitis
B94.1Sequelae of viral encephalitis

Autoimmune and Non-Infectious Encephalitis (G04.x)

CodeDescription
G04.00Acute disseminated encephalitis and encephalomyelitis, unspecified
G04.01Postinfectious acute disseminated encephalitis and encephalomyelitis (ADEM)
G04.02Postimmunization acute disseminated encephalitis, myelitis and encephalomyelitis
G04.11Postinfectious acute necrotizing hemorrhagic encephalopathy
G04.30Acute necrotizing hemorrhagic encephalopathy, unspecified
G04.31Postinfectious acute necrotizing hemorrhagic encephalopathy
G04.32Postimmunization acute necrotizing hemorrhagic encephalopathy
G04.39Other acute necrotizing hemorrhagic encephalopathy
G04.81Other encephalitis and encephalomyelitis (autoimmune encephalitis, including anti-NMDA receptor encephalitis)
G04.89Other encephalitis and encephalomyelitis, other specified
G04.90Encephalitis and encephalomyelitis, unspecified
G04.91Myelitis, unspecified

Encephalitis as Manifestation of Classified Disease (G05.x)

CodeDescription
G05.3Encephalitis and encephalomyelitis in diseases classified elsewhere (manifestation code — always sequence underlying condition first)
G05.4Myelitis in diseases classified elsewhere (manifestation code)

Sequelae and Residuals (B94.1 / G09)

CodeDescription
B94.1Sequelae of viral encephalitis
G09Sequelae of inflammatory diseases of central nervous system

Toxic / Metabolic Encephalopathy — Distinguish from Encephalitis (G92.x / G93.x)

CodeDescription
G92.00Immune effector cell-associated neurotoxicity syndrome, grade unspecified
G92.01Immune effector cell-associated neurotoxicity syndrome, grade 1
G92.02Immune effector cell-associated neurotoxicity syndrome, grade 2
G92.03Immune effector cell-associated neurotoxicity syndrome, grade 3
G92.04Immune effector cell-associated neurotoxicity syndrome, grade 4
G92.05Immune effector cell-associated neurotoxicity syndrome, grade 5
G92.09Other immune effector cell-associated neurotoxicity
G92.8Other toxic encephalopathy
G92.9Unspecified toxic encephalopathy
G93.40Encephalopathy, unspecified
G93.41Metabolic encephalopathy
G93.49Other encephalopathy

CPT CodeDescription
62270Spinal puncture, lumbar, diagnostic (CSF analysis — primary diagnostic procedure for encephalitis workup)
95812Electroencephalogram (EEG); 41-60 minutes (evaluation for seizure activity and encephalitic patterns)
95813Electroencephalogram (EEG); greater than 1 hour
95816Electroencephalogram (EEG); awake and drowsy
95819Electroencephalogram (EEG); awake and asleep
95950Monitoring for localization of cerebral seizure focus, 24 hours (video EEG monitoring — used in encephalitis with refractory seizures)
86596Antinuclear antibody (ANA) titer (autoimmune encephalitis workup)
86235Antinuclear antibody (ANA), DNA antibody
86255Fluorescent antibody; screen, each antibody (autoimmune CNS antibody panel)
87529Herpes simplex virus, HSV; direct probe technique (CSF HSV PCR — key for HSV encephalitis diagnosis)
87531Herpes simplex virus, HSV; amplified probe technique
87798Infectious agent detection by nucleic acid (DNA or RNA), not otherwise specified; amplified probe technique (arbovirus/West Nile PCR)
86800Thyroid antibody (anti-thyroid peroxidase — included in autoimmune encephalitis panels)
99232Subsequent hospital care, moderate complexity (typical daily management code for encephalitis admission)
99233Subsequent hospital care, high complexity

⚠️ Coding Note: The single most important distinction in inpatient encephalitis coding is separating true encephalitis (inflammatory, G04.x or etiology-specific A8x/B0x codes) from encephalopathy (metabolic/toxic/structural dysfunction, G92.x/G93.4x) — physicians routinely use these terms interchangeably in clinical documentation, but they represent distinct pathophysiological processes and code to entirely different categories; when documentation is ambiguous and CSF shows pleocytosis or MRI shows parenchymal signal change, query the attending to clarify whether “encephalopathy” meets the clinical definition of encephalitis before assigning G04.x codes. For infectious encephalitis, sequencing follows etiology-first logic: when a specific organism is identified (e.g., HSV → B00.4, West Nile → A92.31), the organism-specific code is sequenced as the principal diagnosis and manifestation codes (G05.3) are added when required by the Tabular — do not default to A86 unspecified when a confirmed pathogen is in the record. An undercoding alert for inpatient profee: autoimmune and anti-NMDA receptor encephalitis (G04.81) is frequently missed and coded to G04.90 unspecified or even to encephalopathy — documentation triggers include “psychiatric symptoms in young woman,” “new-onset refractory seizures,” “CSF lymphocytic pleocytosis with negative cultures,” or “paraneoplastic workup ordered”; query when these patterns appear without a specific encephalitis code. Sequelae of encephalitiscognitive deficits, epilepsy, behavioral changes — should be captured with B94.1 (viral) or G09 (other inflammatory) as appropriate, plus individual residual codes (e.g., G40.x for post-encephalitic epilepsy, F07.89 for personality change due to known physiological condition).



Med roots dictionary Appendix A Prefixes Appendix B Combining Forms Appendix C Suffixes Appendix D Suffix forms